Table 3.
Self-Reported Method | Only Expected Hormones(s), % (n) | Expected & Unexpected Hormones, % (n) | Only Unexpected Hormone(s), % (n) | No Hormones, % (n) |
---|---|---|---|---|
Injectable | 81.0% (205) | 1.6% (4) | 0.8% (2) | 16.6% (42) |
| ||||
HIV-infected | 87.8% (79) | 0% (0) | 0% (0) | 12.2% (11) |
HIV-uninfected | 77.3% (126) | 2.5% (4) | 1.2% (2) | 19.0% (31) |
| ||||
OC | 27.3% (18) | 6.1% (4) | 4.5% (3) | 62.1% (41) |
| ||||
HIV-infected | 29.2% (7) | 8.3% (2) | 12.5% (3) | 50.0% (12) |
HIV-uninfected | 26.2% (11) | 4.8% (2) | 0% (0) | 69.0% (29) |
| ||||
Implant | 89.7% (35) | 2.6% (1) | 0% (0) | 7.7% (3) |
| ||||
HIV-infected | 75.0% (3) | 25.0% (1) | 0% (0) | 0% (0) |
HIV-uninfected | 91.4% (32) | 0% (0) | 0% (0) | 8.6% (3) |
| ||||
None* | 86.3% (642) | N/A | 13.7% (102) | N/A |
| ||||
HIV-infected | 85.4% (252) | N/A | 14.6% (43) | N/A |
HIV-uninfected | 86.9% (390) | N/A | 13.1% (59) | N/A |
| ||||
Total | 81.7% (900) | 0.8% (9) | 9.7% (107) | 7.8% (86) |
For non-users, expected hormones=none.